?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 6 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Zhejiang Ausun Pharmaceutical Co Ltd | 61.5 | Arzneimittel (Biotechnologie) | China | 0.9 Mrd. USD | 77.02 | 245.86 | 8.02 | 2.61 | ▲ 14.14% | ▲ 8.50% | 0.85% | - | 3 Jahre | 16.47% | ▼ -2.31% | 17.49% | ▼ -2.46% | 6.57% | ▲ 8.94% | 6 / 9 | 6,49 | 28-fach | 14 / 100 | −0,8 / 100 | −2,75 |
 | Bristol-Myers Squibb Company | 61.4 | Arzneimittel (Pharmazeutisch) | USA | 130.0 Mrd. USD | 14.01 | 11.36 | 2.64 | 5.82 | ▲ 2.54% | - | 3.96% | ▲ 5.15% | 4 Jahre | 14.64% | ▼ -3.31% | 28.48% | ▲ 1.57% | 26.65% | ▼ -0.94% | 8 / 9 | 2,16 | 3-fach | 38 / 100 | −7,9 / 100 | −2,84 |
 | Celltrion Inc | 61.4 | Arzneimittel (Biotechnologie) | Südkorea | 28.6 Mrd. USD | 25.93 | 74.47 | 8.34 | 2.28 | ▲ 17.62% | ▲ 14.74% | 0.40% | - | 2 Jahre | 24.74% | ▼ -2.28% | 27.78% | ▼ -3.81% | 7.55% | ▼ -1.70% | 6 / 9 | 5,16 | 16-fach | 11 / 100 | 1,7 / 100 | −2,16 |
| Joincare Pharmaceutical Group Industry Co Ltd | 61.3 | Arzneimittel (Pharmazeutisch) | China | 2.5 Mrd. USD | 14.11 | 36.08 | 1.22 | 1.11 | ▲ 2.39% | ▲ 3.57% | 2.38% | ▲ 2.02% | - | 8.78% | ▲ 0.10% | 20.94% | ▲ 0.72% | 20.54% | ▲ 2.85% | 7 / 9 | 7,32 | 28-fach | 36 / 100 | −9,8 / 100 | −3,48 |
| Hanmi Science | 61.1 | Arzneimittel (Pharmazeutisch) | Südkorea | 2.4 Mrd. USD | 22.57 | 130.05 | 2.45 | 3.21 | ▲ 9.62% | ▲ 39.26% | 0.60% | - | - | 8.72% | ▲ 0.64% | 4.20% | ▲ 0.26% | 1.97% | ▲ 0.69% | 7 / 9 | 3,96 | 11-fach | 21 / 100 | 4,7 / 100 | −2,28 |
 | UCB SA | 60.6 | Arzneimittel (Pharmazeutisch) | Belgien | 45.4 Mrd. USD | 17.87 | 26.27 | 4.60 | 3.36 | ▲ 7.68% | ▲ 16.31% | 0.72% | ▲ 2.69% | 16 Jahre | 20.13% | ▲ 1.34% | 15.06% | ▲ 0.47% | 24.31% | ▲ 1.33% | 8 / 9 | 4,44 | 9-fach | 30 / 100 | −3,3 / 100 | −2,38 |
| Yili Chuanning Biotechnology Co. Ltd. A | 60.5 | Arzneimittel (Biotechnologie) | China | 2.7 Mrd. USD | 41.97 | - | 5.57 | 2.29 | - | - | 2.11% | - | - | 16.66% | ▲ 4.00% | 22.11% | ▲ 3.09% | 9.79% | ▼ -1.34% | 5 / 9 | 6,51 | 22-fach | 13 / 100 | 2,1 / 100 | −1,99 |
 | Innoviva Inc | 60.5 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 4.18 | 7.93 | 3.37 | 1.21 | ▲ 4.77% | ▲ 3.86% | - | - | - | 63.78% | ▼ -6.62% | 38.52% | ▼ -13.04% | 43.85% | ▼ -10.56% | 6 / 9 | 7,33 | 11-fach | 19 / 100 | 4,5 / 100 | −2,26 |
 | MannKind Corp | 60.3 | Arzneimittel (Biotechnologie) | USA | 1.2 Mrd. USD | - | - | 3.06 | -17.94 | ▲ 39.89% | - | - | - | - | 1.68% | ▲ 31.52% | 11.12% | ▲ 23.66% | 3.92% | ▲ 30.18% | 6 / 9 | −11,95 | 1-fach | 36 / 100 | −1,6 / 100 | 0,71 |
| Santen Pharmaceutical Co. Ltd | 60.2 | Arzneimittel (Pharmazeutisch) | Japan | 4.2 Mrd. USD | 16.63 | 18.32 | 2.21 | 2.17 | ▲ 3.29% | ▲ 40.66% | 2.05% | ▼ -4.00% | - | 12.81% | ▲ 2.26% | 15.50% | ▲ 2.08% | 12.57% | ▲ 3.11% | 8 / 9 | 7,14 | 18-fach | 38 / 100 | −1,5 / 100 | −2,51 |
 | Royalty Pharma Plc | 60.1 | Arzneimittel (Pharmazeutisch) | USA | 33.9 Mrd. USD | 41.54 | 11.38 | 13.35 | 4.96 | ▲ 2.30% | ▼ -4.59% | 1.60% | ▲ 6.69% | 5 Jahre | 32.42% | ▲ 4.67% | 65.58% | ▲ 4.95% | 104.69% | ▲ 15.09% | 5 / 9 | 1,82 | 7-fach | 15 / 100 | −10,5 / 100 | 5,50 |
| Zhejiang Wolwo Bio-Pharmaceutical Co Ltd | 60.0 | Arzneimittel (Pharmazeutisch) | China | 1.5 Mrd. USD | 23.81 | 335.25 | 9.10 | 3.61 | ▲ 10.80% | ▲ 6.47% | 1.32% | - | 1 Jahre | 35.86% | ▼ -1.66% | 39.01% | ▼ -2.36% | 28.60% | ▼ -0.54% | 9 / 9 | 21,60 | > 50-fach | 36 / 100 | −1,5 / 100 | −3,05 |
 | Jilin Aodong Pharmaceutical Group Co Ltd | 59.9 | Arzneimittel (Pharmazeutisch) | China | 3.1 Mrd. USD | 6.67 | 2171.91 | 9.42 | 0.66 | ▲ 0.73% | ▲ 6.99% | 2.83% | ▲ 8.45% | - | 102.57% | ▲ 4.79% | -2.69% | ▼ -14.04% | 6.16% | ▼ -0.22% | 6 / 9 | 12,18 | 20-fach | 3 / 100 | 6,2 / 100 | −2,94 |
 | SIGA Technologies Inc | 59.7 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 4.06 | 1.32 | ▼ -5.41% | ▼ -16.19% | 9.45% | - | - | 24.63% | ▼ -4.26% | 25.05% | ▼ -7.13% | 45.58% | ▲ 7.16% | 6 / 9 | 16,23 | unbegrenzt | 30 / 100 | −9,2 / 100 | −4,02 |
 | HUTCHMED China Ltd | 59.4 | Arzneimittel (Pharmazeutisch) | Hong Kong | 2.3 Mrd. USD | 4.83 | - | 3.75 | 1.84 | ▲ 19.20% | - | - | - | - | 83.30% | ▲ 36.65% | -9.95% | ▲ 25.36% | -14.37% | ▲ 16.42% | 5 / 9 | 8,63 | > 50-fach | 12 / 100 | 30,0 / 100 | −1,19 |
| Changzhou Qianhong Biopharma Co Ltd | 59.3 | Arzneimittel (Pharmazeutisch) | China | 1.2 Mrd. USD | 27.51 | - | 5.50 | 2.95 | ▼ -1.18% | - | 2.38% | ▲ 4.56% | - | 25.38% | ▲ 4.07% | 21.16% | ▲ 3.03% | 13.99% | ▲ 6.05% | 6 / 9 | 14,94 | > 50-fach | 30 / 100 | 1,2 / 100 | −2,89 |
 | Kuros Biosciences AG | 59.2 | Arzneimittel (Biotechnologie) | Schweiz | 0.9 Mrd. USD | 90.02 | - | 5.21 | 10.04 | ▲ 97.48% | - | - | - | - | 2.10% | ▲ 18.96% | 6.04% | ▲ 20.71% | -1.98% | ▲ 12.62% | 5 / 9 | 3,08 | −11,5-fach | 98 / 100 | 2,7 / 100 | −1,71 |
| Zhejiang Jiuzhou Pharm Co Ltd | 58.9 | Arzneimittel (Pharmazeutisch) | China | 1.9 Mrd. USD | 21.59 | - | 2.45 | 1.44 | ▲ 15.78% | ▲ 13.92% | 1.38% | - | 1 Jahre | 13.25% | ▼ -0.99% | 22.39% | ▲ 0.15% | 21.13% | ▲ 3.00% | 9 / 9 | 9,14 | > 50-fach | 19 / 100 | −10,4 / 100 | −3,04 |
| Anhui Huaheng Biotechnology Co. Ltd. A | 58.3 | Arzneimittel (Biotechnologie) | China | 0.6 Mrd. USD | 35.60 | - | 1.37 | 1.54 | ▲ 42.49% | ▲ 1.80% | 0.96% | ▼ -0.04% | - | 4.63% | ▼ -3.99% | 4.53% | ▼ -4.50% | -18.60% | ▼ -4.56% | 5 / 9 | 1,87 | 9-fach | 11 / 100 | 0,5 / 100 | −1,88 |
 | Ligand Pharmaceuticals Incorporated | 58.3 | Arzneimittel (Pharmazeutisch) | USA | 5.7 Mrd. USD | 28.76 | 43.17 | 19.52 | 5.86 | ▲ 10.39% | - | - | - | - | 46.42% | ▲ 5.98% | 17.61% | ▼ -6.59% | 18.24% | ▼ -3.63% | 7 / 9 | 7,28 | 28-fach | 17 / 100 | 4,8 / 100 | −1,79 |
| Yabao Pharmaceutical Group Co Ltd | 58.1 | Arzneimittel (Pharmazeutisch) | China | 0.7 Mrd. USD | 14.19 | 47.42 | 2.04 | 1.63 | ▼ -2.95% | ▲ 24.41% | 8.30% | ▼ -12.94% | - | 14.29% | ▲ 2.02% | 15.61% | ▲ 2.31% | 23.43% | ▲ 2.37% | 8 / 9 | 10,95 | 46-fach | 35 / 100 | −7,6 / 100 | −3,57 |
| Zhangzhou Pientzehuang Pharmaceutical Co Ltd | 58.0 | Arzneimittel (Pharmazeutisch) | China | 10.8 Mrd. USD | 39.92 | - | 8.81 | 4.94 | ▲ 6.69% | ▲ 5.25% | 2.48% | - | 5 Jahre | 23.98% | ▼ -1.35% | 25.00% | ▼ -2.28% | -2.92% | ▼ -8.98% | 5 / 9 | 12,52 | > 50-fach | 19 / 100 | 12,2 / 100 | −2,38 |
 | Pacific Shuanglin Bio pharmacy Co Ltd | 57.9 | Arzneimittel (Pharmazeutisch) | China | 1.4 Mrd. USD | 35.60 | - | 3.85 | 1.18 | ▲ 20.18% | ▲ 17.66% | - | - | 3 Jahre | 15.93% | ▼ -0.42% | 22.28% | ▲ 0.34% | -20.87% | ▼ -6.36% | 2 / 9 | 9,13 | > 50-fach | 12 / 100 | 6,7 / 100 | −1,94 |
 | Xeris Pharmaceuticals Inc | 57.8 | Arzneimittel (Pharmazeutisch) | USA | 1.4 Mrd. USD | - | 24.53 | 4.05 | -139.54 | ▲ 154.71% | - | - | - | - | 0.19% | ▲ 55.42% | 8.53% | ▲ 53.92% | 9.57% | ▲ 48.40% | 7 / 9 | −2,91 | −0,4-fach | 62 / 100 | −7,3 / 100 | −2,57 |
 | Genmab A/S | 57.8 | Arzneimittel (Biotechnologie) | Dänemark | 19.9 Mrd. USD | 163.20 | 147.87 | 13.34 | 21.59 | ▼ -17.52% | ▼ -26.81% | - | - | - | 25.89% | ▼ -2.08% | 33.60% | ▼ -1.34% | 30.89% | ▲ 2.56% | 5 / 9 | 3,34 | > 50-fach | 28 / 100 | −1,8 / 100 | −3,90 |
